Skip to main content
Top
Published in: Pathology & Oncology Research 4/2016

01-10-2016 | Original Article

Trends in Gastrointestinal Cancer Mortality Rate in Hungary

Authors: Klaudia Farkas, Mónika Szűcs, Tibor András Nyári

Published in: Pathology & Oncology Research | Issue 4/2016

Login to get access

Abstract

The aim of this study was to investigate the annual death trends for gastrointestinal cancer in Hungary between 1963 and 2012. Data on the numbers of cancer deaths were obtained from the published nationwide population register. Numbers of deaths from esophageal, gastric and colorectal cancer were available during the study period. However, the mortality data for hepatic, pancreatic and gallbladder cancer have been published only since 1979. Joinpoint regression was applied to investigate the annual trends in the rates of cancer mortality. The annual mortality rates of gastric and gallbladder cancer decreased throughout the study period. Furthermore, declines in mortality from esophageal and hepatic cancers have been observed since 1998 and 1995, respectively. However, the rates of colorectal and pancreatic cancer mortality have been increasing in the past few years. Nevertheless, the mortality rates of colorectal and pancreatic cancers have increased in males aged 40–59 years during the study period. Moreover, significantly higher risks of gastrointestinal cancer-related deaths have been observed in males as compared with females except for death related to cancer of the gallbladder. The presented data suggest that the Hungarian mortality rates are particularly high. The detection of gastrointestinal cancers at an early stage would significantly improves the outcome of these malignancies.
Literature
1.
go back to reference Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. (2015) Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefPubMed Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. (2015) Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972):977–1010CrossRefPubMed
2.
go back to reference The Hungarian Central Statistical Office. Demographic Yearbook (1963-2012) Budapest. KSH 2013 The Hungarian Central Statistical Office. Demographic Yearbook (1963-2012) Budapest. KSH 2013
3.
go back to reference Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403CrossRefPubMed
4.
go back to reference Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, La Vecchia C (2013) Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 24:2657–2671CrossRefPubMed Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, La Vecchia C (2013) Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 24:2657–2671CrossRefPubMed
5.
go back to reference Jemal A, Center MM, DeSantis C, Ward EM (2010) Global Patterns of Cancer Incidence and Mortality Rates and Trends. Cancer Epidemiol Biomark Prev 19:1893–1907CrossRef Jemal A, Center MM, DeSantis C, Ward EM (2010) Global Patterns of Cancer Incidence and Mortality Rates and Trends. Cancer Epidemiol Biomark Prev 19:1893–1907CrossRef
6.
go back to reference Szabolcs O (2003) Cancer epidemiology in Hungary and the Béla Johan National Program for the decade of health. Pathol Oncol Res 9:126–130CrossRefPubMed Szabolcs O (2003) Cancer epidemiology in Hungary and the Béla Johan National Program for the decade of health. Pathol Oncol Res 9:126–130CrossRefPubMed
7.
go back to reference Péter A (2013) Connection between cancer- and alcohol-related mortality in a rural practice of a South-Hungarian village. Orv Hetil 154:700–706CrossRefPubMed Péter A (2013) Connection between cancer- and alcohol-related mortality in a rural practice of a South-Hungarian village. Orv Hetil 154:700–706CrossRefPubMed
8.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351CrossRefPubMed Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351CrossRefPubMed
9.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMed
10.
go back to reference Spallek J, Arnold M, Razum O, Juel K, Rey G, Deboosere P, Mackenbach JP, Kunst AE (2012) Cancer mortality patterns among Turkish immigrants in four European countries and in Turkey. Eur J Epidemiol 27:915–921CrossRefPubMed Spallek J, Arnold M, Razum O, Juel K, Rey G, Deboosere P, Mackenbach JP, Kunst AE (2012) Cancer mortality patterns among Turkish immigrants in four European countries and in Turkey. Eur J Epidemiol 27:915–921CrossRefPubMed
11.
go back to reference Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591–1602CrossRefPubMed Randi G, Franceschi S, La Vecchia C (2006) Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 118:1591–1602CrossRefPubMed
12.
go back to reference Levi F, Lucchini F, Negri E, La Vecchia C (2004) Trends in Mortality from Major Cancers in The European Union, Including Acceding Countries, in 2004. Cancer 101:2843–2850CrossRefPubMed Levi F, Lucchini F, Negri E, La Vecchia C (2004) Trends in Mortality from Major Cancers in The European Union, Including Acceding Countries, in 2004. Cancer 101:2843–2850CrossRefPubMed
13.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRefPubMed
14.
go back to reference Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, La Vecchia C (2011) Recent trends in colorectal cancer mortality in Europe. Int J Cancer 129:180–191CrossRefPubMed Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, La Vecchia C (2011) Recent trends in colorectal cancer mortality in Europe. Int J Cancer 129:180–191CrossRefPubMed
15.
go back to reference Sunkara V (2015) Hébert JR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care Cancer 121:1563–1569PubMed Sunkara V (2015) Hébert JR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care Cancer 121:1563–1569PubMed
16.
go back to reference Ll H, Tulassay Z (2010) Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14:249–258 Ll H, Tulassay Z (2010) Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14:249–258
17.
go back to reference Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50:1330–1344CrossRefPubMed Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50:1330–1344CrossRefPubMed
18.
go back to reference de Vries E, Arroyave I, Pardo C, Wiesner C, Murillo R, Forman D, Burdorf A, Avendaño M (2015) Trends in inequalities in premature cancer mortality by educational level in Colombia, 1998-2007. J Epidemiol Community Health 69:408–415CrossRefPubMed de Vries E, Arroyave I, Pardo C, Wiesner C, Murillo R, Forman D, Burdorf A, Avendaño M (2015) Trends in inequalities in premature cancer mortality by educational level in Colombia, 1998-2007. J Epidemiol Community Health 69:408–415CrossRefPubMed
19.
go back to reference Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014) Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev 23:700–713CrossRef Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F (2014) Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomark Prev 23:700–713CrossRef
20.
go back to reference AEl S, RA D'A Jr, RA B, DC S (2003) International variation in pancreatic cancer mortality for the period 1955-1998. Eur J Epidemiol 18:801–816 AEl S, RA D'A Jr, RA B, DC S (2003) International variation in pancreatic cancer mortality for the period 1955-1998. Eur J Epidemiol 18:801–816
21.
go back to reference AAl B, LJ S, Volovics A, Dorant E, Den Brandt PA v (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645–654CrossRef AAl B, LJ S, Volovics A, Dorant E, Den Brandt PA v (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29:645–654CrossRef
22.
go back to reference Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, Lemmens VE, van Heijningen EB, Aragonés N, van Ballegooijen M, Inadomi JM (2014) Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol 109:336–343 quiz 335, 344CrossRefPubMed Kroep S, Lansdorp-Vogelaar I, Rubenstein JH, Lemmens VE, van Heijningen EB, Aragonés N, van Ballegooijen M, Inadomi JM (2014) Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands. Am J Gastroenterol 109:336–343 quiz 335, 344CrossRefPubMed
23.
go back to reference Cl C, Bosetti C, Malvezzi M, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol 25:283–290CrossRef Cl C, Bosetti C, Malvezzi M, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol 25:283–290CrossRef
24.
go back to reference Bjerregaard JK, Mortensen MB, Pfeiffer P, Academy of Geriatric Cancer Research (AgeCare) (2016) Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980–2012. Acta Oncol 55(Suppl 1):40–45CrossRefPubMed Bjerregaard JK, Mortensen MB, Pfeiffer P, Academy of Geriatric Cancer Research (AgeCare) (2016) Trends in cancer of the liver, gall bladder, bile duct, and pancreas in elderly in Denmark, 1980–2012. Acta Oncol 55(Suppl 1):40–45CrossRefPubMed
25.
go back to reference Bosch FX, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5–S16 ReviewCrossRefPubMed Bosch FX, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127(5 Suppl 1):S5–S16 ReviewCrossRefPubMed
26.
go back to reference Center MM, Jemal A (2011) International trends in liver cancer incidence rates. Cancer Epidemiol Biomark Prev 20:2362–2368CrossRef Center MM, Jemal A (2011) International trends in liver cancer incidence rates. Cancer Epidemiol Biomark Prev 20:2362–2368CrossRef
27.
go back to reference Döbrőssy L, Kovács A, Budai A, Simon J, Horváth AR, Cornides A, Tulassay Z (2011) Controversial issues in colorectal screening in Hungary: conflict of clinical and public health viewpoints. Orv Hetil 152:1223–1232CrossRefPubMed Döbrőssy L, Kovács A, Budai A, Simon J, Horváth AR, Cornides A, Tulassay Z (2011) Controversial issues in colorectal screening in Hungary: conflict of clinical and public health viewpoints. Orv Hetil 152:1223–1232CrossRefPubMed
Metadata
Title
Trends in Gastrointestinal Cancer Mortality Rate in Hungary
Authors
Klaudia Farkas
Mónika Szűcs
Tibor András Nyári
Publication date
01-10-2016
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 4/2016
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-016-0052-y

Other articles of this Issue 4/2016

Pathology & Oncology Research 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine